These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28158181)

  • 1. Platelet full length TFPI-α in healthy volunteers is not affected by sex or hormonal use.
    Winckers K; Thomassen S; Ten Cate H; Hackeng TM
    PLoS One; 2017; 12(2):e0168273. PubMed ID: 28158181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma.
    Castoldi E; Simioni P; Tormene D; Rosing J; Hackeng TM
    J Thromb Haemost; 2010 Feb; 8(2):294-300. PubMed ID: 20002538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of LDL-associated tissue factor pathway inhibitor.
    Augustsson C; Hilden I; Petersen LC
    Thromb Res; 2014 Jul; 134(1):132-7. PubMed ID: 24787991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic development.
    Ellery PE; Maroney SA; Cooley BC; Luyendyk JP; Zogg M; Weiler H; Mast AE
    Blood; 2015 Jun; 125(26):4078-84. PubMed ID: 25954015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.
    Wood JP; Ellery PE; Maroney SA; Mast AE
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):169-76. PubMed ID: 24233490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of TFPIα to the hemostatic response to injury in mice.
    Marar TT; Martinez ND; Maroney SA; Siebert AE; Wu J; Stalker TJ; Tomaiuolo M; Delacroix S; Simari RD; Mast AE; Brass LF
    J Thromb Haemost; 2021 Sep; 19(9):2182-2192. PubMed ID: 34160126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.
    Harris GM; Stendt CL; Vollenhoven BJ; Gan TE; Tipping PG
    Am J Hematol; 1999 Mar; 60(3):175-80. PubMed ID: 10072106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength.
    Thomassen S; Mastenbroek TG; Swieringa F; Winckers K; Feijge MAH; Schrijver R; Cosemans JMEM; Maroney SA; Mast AE; Hackeng TM; Heemskerk JWM
    Thromb Haemost; 2018 Mar; 118(3):502-513. PubMed ID: 29452445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.
    Tanratana P; Ellery P; Westmark P; Mast AE; Sheehan JP
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):266-274. PubMed ID: 29097362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.
    Thomassen MC; Heinzmann AC; Herfs L; Hartmann R; Dockal M; Scheiflinger F; Hackeng TM; Rosing J
    J Thromb Haemost; 2015 Jan; 13(1):92-100. PubMed ID: 25348176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin generation-based assays to measure the activity of the TFPI-protein S pathway in plasma from normal and protein S-deficient individuals.
    Maurissen LF; Castoldi E; Simioni P; Rosing J; Hackeng TM
    J Thromb Haemost; 2010 Apr; 8(4):750-8. PubMed ID: 20088940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in haemostatic parameters during the menstrual cycle and subsequent use of drospirenone-containing oral contraceptives.
    Tchaikovski SN; Thomassen MC; Costa SD; Bremme K; Rosing J
    Thromb Res; 2014 Nov; 134(5):1032-7. PubMed ID: 25260941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or blood.
    Knappe S; Gorczyca ME; Jilma B; Derhaschnig U; Hartmann R; Palige M; Scheiflinger F; Dockal M
    Thromb Haemost; 2013 Mar; 109(3):450-7. PubMed ID: 23348798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of thrombin generation by TFPI in plasma without and with heparin.
    Brodin E; Appelbom H; Osterud B; Hilden I; Petersen LC; Hansen JB
    Transl Res; 2009 Mar; 153(3):124-31. PubMed ID: 19218095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet-surface-bound proteins during coagulation under flow I: TFPI.
    Miyazawa K; Fogelson AL; Leiderman K
    Biophys J; 2023 Jan; 122(1):99-113. PubMed ID: 36403087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation in vitro and in vivo, and disturbed tissue factor regulation in patients with acute pancreatitis.
    Lindström OK; Tukiainen EM; Kylänpää ML; Mentula PJ; Puolakkainen PA; Wartiovaara-Kautto UM; Repo H; Petäjä JM
    Pancreatology; 2011; 11(6):557-66. PubMed ID: 22213026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma.
    Alshaikh NA; Rosing J; Thomassen MCLGD; Castoldi E; Simioni P; Hackeng TM
    J Thromb Haemost; 2017 May; 15(5):950-960. PubMed ID: 28211163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms.
    Duckers C; Simioni P; Spiezia L; Radu C; Dabrilli P; Gavasso S; Rosing J; Castoldi E
    Blood; 2010 Jan; 115(4):879-86. PubMed ID: 19861681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V east Texas variant causes bleeding in a three-generation family.
    Peterson JA; Gupta S; Martinez ND; Hardesty B; Maroney SA; Mast AE
    J Thromb Haemost; 2022 Mar; 20(3):565-573. PubMed ID: 34847292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.